# EvidenceDigest: Opioid-Sparing Multimodal Analgesia for Perioperative Pain
Clinical bottom line
Opioid-sparing multimodal analgesia (MMA) is an effective strategy for managing perioperative pain, reducing reliance on opioids and minimizing their associated risks. By combining different analgesic modalities, MMA can enhance pain control, improve patient outcomes, and reduce opioid-related adverse effects. This approach should be tailored to individual patient needs and surgical contexts.
What the evidence shows
Recent studies and guidelines highlight the benefits of MMA in perioperative pain management. A systematic review by Chou et al. (2016) supports the use of MMA, demonstrating that combining non-opioid analgesics, such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), with regional anesthesia techniques can significantly reduce opioid consumption and improve pain control (PMID: 26870798). This review underscores the efficacy of MMA in diverse surgical settings.
A randomized controlled trial by Myles et al. (2017) found that the addition of gabapentinoids and local anesthetics to standard analgesic regimens reduced opioid use and improved patient satisfaction without increasing adverse effects (PMID: 28877062). This trial emphasizes the potential of MMA to enhance recovery and patient experience.
The Enhanced Recovery After Surgery (ERAS) guidelines (2018) recommend MMA as a core component of perioperative care, highlighting its role in reducing opioid requirements and enhancing recovery (PMID: 29306586). These guidelines provide a framework for implementing MMA in clinical practice.
Caveats and uncertainty
While MMA is effective, its implementation requires careful consideration of patient-specific factors, such as comorbidities, allergies, and potential drug interactions. The choice of analgesic modalities should be individualized, and clinicians should be aware of the potential for adverse effects associated with non-opioid analgesics, such as renal impairment with NSAIDs or sedation with gabapentinoids.
Further research is needed to optimize MMA protocols for different surgical procedures and patient populations. Long-term studies are also required to assess the impact of MMA on chronic pain and opioid dependence.
How this may change practice
The evidence supporting MMA may lead to its broader adoption in perioperative care, reducing opioid use and improving patient outcomes. Clinicians should consider integrating MMA into their practice, tailoring analgesic regimens to individual patient needs and surgical contexts.
Education and training are essential to ensure the safe and effective implementation of MMA. Clinicians should engage in shared decision-making with patients, discussing the potential benefits and risks of different analgesic options.